MSD Switzerland awarded with the Swiss LGBTI Label
MSD was awarded the “Swiss LGBTI Label”, a certification awarded to companies and organizations with an open and inclusive culture.
Things that count when parenting and working remotely during a pandemic
Stephanie Narain from our Oncology Team shares her experience.
Klaus Beck, Vice President, Medical Affairs, talks about the creation of MSD’s new Innovation and Development Hub in Zurich.
Inventing for Life
MSD is one of the world's leading research-based biopharmaceutical companies. For more than 125 years, we have been developing and providing medicines and vaccines that can improve the health of people and animals and enable them to live better lives.
We strive to provide hope to people with cancer.
MSD operates one of the world's largest and fastest growing clinical research programs in the field of immune-oncology. In Switzerland, we are currently conducting 32 clinical trials (as of 05/2021) in various types of cancer.
Disease prevention
For more than 100 years, we have been researching and developing innovative vaccines to help prevent certain diseases in children, adolescents and adults.
Vaccines: Our History, Our Legacy 
Health protection through vaccination
Research for innovation
Switzerland is one of more than fifty countries in which MSD conducts clinical research. The active substances discovered in the global MSD Research Laboratories are tested in Switzerland in all phases of clinical research.
Why working for MSD is a very good choice.
92% of our employees would recommend MSD as a great place to work
82% of our employees feel that managers support diversity and inclusion
MSD's recent pioneering achievements:
- Gender-neutral parental leave
- Flexible work policy
2021: Awarded Top Employer Switzerland for the 9th and Top Employer Europe for the 6th consecutive time.